As indicated in Supplementary Table S27 and Supplementary Figure S1, the evidence supporting a shared causal variant between HbA1c levels and basal cell carcinoma at the SLC5A2 locus is relatively weak (PP.H4 < 0.80). Here, SLC5A2 is linked to basal cell carcinoma.